Levothyroxine Sodium Tablet
Product Images NDC 51655-728

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 728 52 Master Bottle Label Approval Rev A 06 21)

Label for Levothyroxine Sodium Tablets, USP 88 mcg (0.088 mg) oral tablets. The package contains 30 tablets and is labeled for prescription use only. Storage instructions include keeping at 25°C with allowed excursions, protecting from light and moisture, and keeping out of reach of children. The product is repackaged by Northwind Pharmaceuticals and originally from Lannett Company, Inc.*

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Chemical structure diagram of Levothyroxine Sodium showing its molecular formula with iodine atoms, hydroxyl group, ether linkage, and sodium carboxylate hydrated form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.